Get the Stockscreener App
10.60
0.00%
0.00
Pre-market:
10.57
-0.03
-0.28%
Drugs Made In America Acquisition Corp stock is traded at $10.60, with a volume of 46,310.
It is up +0.00% in the last 24 hours and up +0.81% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.60
Open:
$10.57
24h Volume:
46,310
Relative Volume:
0.31
Market Cap:
$357.40M
Revenue:
-
Net Income/Loss:
$5.94M
P/E Ratio:
59.82
EPS:
0.1772
Net Cash Flow:
$-539.20K
1W Performance:
+0.28%
1M Performance:
+0.81%
6M Performance:
+2.79%
1Y Performance:
+4.95%
1-Day Range:
$10.57
$10.60
1-Week Range:
$10.56
$10.60
52-Week Range:
$10.09
$10.60
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
646-726-7074
Address
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.60 | 357.40M | 0 | 5.94M | -539.20K | 0.1772 |
LION
Lionsgate Studios Corp
|
12.24 | 3.55B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
8.62 | 2.99B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
13.42 | 641.31M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.64M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.15 | 592.76M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Macro Trends - Newser
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử Tỉnh Sơn La
US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành
Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America Acquisition II (DMII) logs $4.2M income, flags going-concern risk - Stock Titan
Paloma Acquisition Corp I: Performance & Quotes, PALO Stock Price on Nasdaq Exchange - marketscreener.com
Drugs Made in America (DMAA) asks investors to extend SPAC deal deadline - Stock Titan
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest - MarketBeat
Drugs Made In America Acquisition II Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Chipmakers Recap: Can Drugs Made In America Acquisition Corp Equity Right sustain earnings growth2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
Weekly Recap: Is Drugs Made In America Acquisition Corp a momentum stock2026 Stock Rankings & High Conviction Trade Alerts - baoquankhu1.vn
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Aug Chart Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2026 Patterns & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%What's Next? - MarketBeat
Targets Report: Can Drugs Made In America Acquisition Corp Equity Right deliver alphaStop Loss & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Drugs Made In America Acquisition Corp. Signs LOI for De-SPAC Merger with Power Analytics Global Corp - Minichart
Power Analytics Global Corp signed a letter of intent to acquire Drugs Made In America Acquisition Corp. in a reverse merger transaction for $1.0 billion. - marketscreener.com
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Competitors - Meyka
Drugs Made in America SPAC Signs Power Analytics LOI - TipRanks
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):